India Creates Government Drug R&D Promotion Board
This article was originally published in PharmAsia News
Executive Summary
India's Health and Welfare Ministry has established a new panel aimed at strengthening research and development in the nation's pharmaceutical industry. The panel is to be named the Drug Development Promotion Board, as recommended by an earlier special committee. The board is to be backed by a pharmaceutical research, development and support fund under the Department of Science and Technology for development of new drugs. The intention is to encourage collaborative R&D projects. (Click here for more
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.